It is well established that the P2Y6 receptor is abundantly expressed in atherosclerotic lesions of low-density lipoprotein receptor (LDLR) knockout mice, and the knockout of the P2Y6 receptor will alleviate atherosclerosis and plaque inflammation [16, 17]. Here, LDLR is linked to atherosclerosis.